What are the non-pharmacologic and pharmacologic treatment recommendations for a patient with anxiety, insomnia, and substance use issues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Pharmacologic Recommendations for Insomnia with Anxiety and Substance Use Issues

Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for MJ's insomnia due to its superior long-term efficacy, minimal adverse effects, and effectiveness in patients with substance use disorders. 1, 2

Primary Non-Pharmacologic Interventions

  • CBT-I has been shown to be more effective than pharmacotherapy in the long-term management of chronic insomnia and should be implemented before considering medication options 1
  • CBT-I is particularly valuable for patients with substance use disorders as it avoids introducing potentially addictive medications 3, 4
  • Key components of effective CBT-I include:
    • Sleep restriction therapy - limiting time in bed to match actual sleep time to improve sleep efficiency 1
    • Stimulus control - breaking negative associations between the bed/bedroom and wakefulness 1, 2
    • Cognitive restructuring - addressing maladaptive thoughts and beliefs about sleep 1, 2

Specific Behavioral Techniques

  • Sleep restriction therapy: Based on sleep logs, limit time in bed to the actual sleep time (but not less than 5 hours), then gradually increase as sleep efficiency improves above 85% 1
  • Stimulus control instructions:
    • Go to bed only when sleepy
    • Use the bed only for sleep
    • Leave the bed if unable to fall asleep within approximately 20 minutes
    • Return to bed only when sleepy again
    • Maintain a regular wake-up time regardless of sleep duration 1
  • Relaxation training: Progressive muscle relaxation to reduce somatic and cognitive arousal that interferes with sleep 1

Additional Non-Pharmacologic Approaches

  • Regular exercise, particularly aerobic activities like walking or jogging, can help reduce anxiety symptoms and improve sleep quality 1, 5
  • For anxiety management, incorporate specific techniques:
    • Deep breathing exercises
    • Mindfulness practices
    • Problem-solving skills 1, 5
  • Sleep hygiene education (as part of comprehensive treatment, not as standalone therapy):
    • Avoid caffeine, alcohol, and nicotine, especially in the evening
    • Create a comfortable sleep environment
    • Establish consistent sleep-wake times
    • Avoid daytime napping 1, 2

Special Considerations for Substance Use

  • The relationship between insomnia and substance use disorders is bidirectional - each can exacerbate the other 3, 4
  • Regular reassessment of sleep patterns throughout substance use treatment is essential 3
  • For patients with substance use disorders, non-pharmacological approaches should be strongly emphasized to avoid triggering or worsening substance use issues 4, 6

Implementation Considerations

  • While CBT-I is highly effective, access to trained practitioners may be limited 7
  • Self-help CBT-I materials (such as weekly booklets providing information on components of CBT-I) have shown clinically significant improvements in insomnia severity, sleep efficiency, and sleep quality 1
  • Brief, focused CBT interventions that include psychoeducation, exercise prescription, and psychosocial support can be effective when delivered in primary care settings 5

Common Pitfalls to Avoid

  • Relying solely on sleep hygiene education, which is insufficient as a standalone treatment for chronic insomnia 1, 2
  • Using sedating substances (including alcohol) to self-medicate sleep problems, which can worsen both insomnia and substance use issues in the long term 4, 6
  • Failing to address underlying anxiety that may be contributing to sleep difficulties 1
  • Neglecting to provide adequate follow-up and support during implementation of behavioral techniques 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insomnia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Substance abuse and insomnia.

Minnesota medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.